(Q46220507)

20 December 2017

title

Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study (English)

1 reference

20 December 2017

0 references

Eiad A Ramzy

1

1 reference

20 December 2017

language of work or name

1 reference

19 February 2016

1 reference

20 December 2017

published in

Pain Practice

1 reference

20 December 2017

volume

17

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

32-40

1 reference

20 December 2017

Fibromyalgia: nosography and therapeutic perspectives.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Anxiety, depression and alexithymia in fibromyalgia: are there any differences according to age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Etiology and pathophysiology of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

The Use of Antidepressants in the Long-Term Treatment Should not Improve the Impact of Fibromyalgia on Quality of Life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Newer antidepressants and panic disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Is there a role for cytokine based therapies in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

An update on pharmacotherapy for the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Paroxetine in the treatment of dysthymic disorder without co-morbidities: A double-blind, placebo-controlled, flexible-dose study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Fibromyalgia comorbid with anxiety disorders and depression: combined medical and psychological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Venlafaxine Treatment of Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

Fibromyalgia diagnosis: a review of the past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPAPR.12409

21 January 2018

Identifiers

DOI

10.1111/PAPR.12409

1 reference

20 December 2017

PubMed ID

26892006

1 reference

20 December 2017